Nerea Ugidos-Damboriena

ORCID: 0000-0003-4938-3973
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Research and Splicing
  • Hematopoietic Stem Cell Transplantation
  • Cancer Genomics and Diagnostics
  • Multiple Myeloma Research and Treatments
  • Immune Response and Inflammation
  • RNA regulation and disease
  • Cytokine Signaling Pathways and Interactions
  • Neuroinflammation and Neurodegeneration Mechanisms
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Multiple Sclerosis Research Studies
  • RNA Interference and Gene Delivery
  • Immune cells in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • CRISPR and Genetic Engineering
  • Genetically Modified Organisms Research
  • Cancer Cells and Metastasis
  • T-cell and Retrovirus Studies
  • Viral gastroenteritis research and epidemiology
  • Genetics, Bioinformatics, and Biomedical Research
  • Epigenetics and DNA Methylation
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Diabetes and associated disorders
  • Genomics and Chromatin Dynamics
  • Law, AI, and Intellectual Property

Lund University
2021-2024

BioCruces Health research Institute
2024

Navarrabiomed
2022

Universidad de Navarra
2022

Stem Cell Institute
2022

Institute for Stem Cell Biology and Regenerative Medicine
2020

University of the Basque Country
2014-2019

Achucarro Basque Center for Neuroscience
2015-2019

Universidad de Oviedo
2013

Universitat de Lleida
2011

Abstract Thousands of non-coding variants have been associated with increased risk human diseases, yet the causal and their mechanisms-of-action remain obscure. In an integrative study combining massively parallel reporter assays (MPRA), expression analyses (eQTL, meQTL, PCHiC) chromatin accessibility in primary cells (caQTL), we investigate 1,039 multiple myeloma (MM). We demonstrate that MM susceptibility is mediated by gene-regulatory changes plasma B-cells, identify putative at six loci...

10.1038/s41467-021-27666-x article EN cc-by Nature Communications 2022-01-10

Abstract Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 which are novel. Through functional fine-mapping Mendelian randomization, uncover two causal for inherited risk: longer telomeres; elevated levels B-cell maturation antigen (BCMA)...

10.1038/s41467-024-50932-7 article EN cc-by Nature Communications 2024-08-05

<h3>Objective</h3> A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data sufficiently sized and independent sets are needed to assess whether these represent genuine MS risk factors. <h3>Methods</h3> The lead SNPs of all were genotyped 10 796 cases 793 controls from Germany, Spain, France, Netherlands, Austria Russia, previously cohorts. Association analyses performed...

10.1136/jmedgenet-2015-103442 article EN Journal of Medical Genetics 2015-10-16

Abstract Background Cytogenetic and gene expression analyses in head neck squamous cell carcinomas (HNSCC) have allowed identification of genomic aberrations that may contribute to cancer pathophysiology. Nevertheless, the molecular consequences numerous genetic alterations still remain unclear. Methods To identify novel genes implicated HNSCC pathogenesis, we analyzed present five HNSCC-derived lines by array CGH, compared high level focal amplifications with levels whose is directly...

10.1186/1471-2407-13-116 article EN cc-by BMC Cancer 2013-03-14

An intronic variant in ANKRD55, rs6859219, is a genetic risk factor for multiple sclerosis, but the biological reasons underlying this association are unknown. We characterized expression of ANKRD55 human PBMCs and cell lines. Three transcript variants (Ensembl isoforms 001, 005, 007) could be detected CD4(+) T cells were virtually absent CD8(+), CD14(+), CD19(+), CD56(+) cells. Rs6859219 was significantly associated with levels and, thus, coincides cis-expression quantitative trait locus....

10.4049/jimmunol.1501205 article EN The Journal of Immunology 2016-05-05

The ankyrin repeat domain-55 (ANKRD55) gene contains intronic single nucleotide polymorphisms (SNPs) associated with risk to contract multiple sclerosis, rheumatoid arthritis or other autoimmune disorders. Risk alleles of these SNPs are higher levels ANKRD55 in CD4+ T cells. biological function is unknown, but given that domains constitute one the most common protein-protein interaction platforms nature, it likely complex proteins. Thus, identification its protein interactomes may provide...

10.3389/fimmu.2019.02067 article EN cc-by Frontiers in Immunology 2019-09-18

Abstract Introduction SNPs associated with genome-wide risk for multiple sclerosis (MS) modulate expression of ankyrin repeat domain protein 55 (ANKRD55). The function ANKRD55 is not well understood. A role in ciliar transport multiciliated cells has been reported. To gain deeper insight how may neuro-inflammatory parameters, we identified the interactomes from human neuroblastoma, astrocytic, microglial and monocytic cell lines. Methods Cell lines were transfected synthetic RNA conjunction...

10.1101/2024.03.18.584613 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-03-19

ABSTRACT Understanding how hematopoietic stem and progenitor cells (HSPCs) are regulated is of central importance for the development new therapies blood disorders cell transplantation. To date, HSPC regulation has been extensively studied in vitro animal models, but less known about mechanisms vivo humans. Here, a genome-wide association study on 13,167 individuals, we identify 9 significant 2 suggestive DNA sequence variants that influence (CD34 + ) levels human blood. The identified loci...

10.1101/2021.03.31.437808 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-04-01
Coming Soon ...